Cargando…

Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis

Tuberculosis remains a serious threat worldwide. For this reason, it is necessary to identify agents that shorten the duration of treatment, strengthen the host immune system, and/or decrease the damage caused by the infection. Statins are drugs that reduce plasma cholesterol levels and have immunom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guerra-De-Blas, Paola Del Carmen, Bobadilla-Del-Valle, Miriam, Sada-Ovalle, Isabel, Estrada-García, Iris, Torres-González, Pedro, López-Saavedra, Alejandro, Guzmán-Beltrán, Silvia, Ponce-de-León, Alfredo, Sifuentes-Osornio, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764081/ https://www.ncbi.nlm.nih.gov/pubmed/31616387 http://dx.doi.org/10.3389/fmicb.2019.02097

Ejemplares similares

Potential Effect of Statins on Mycobacterium tuberculosis Infection
por: Guerra-De-Blas, Paola Del Carmen, et al.
Publicado: (2018)

Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000–2015
por: Torres-Gonzalez, Pedro, et al.
Publicado: (2016)

Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
por: Ordaz-Vázquez, Anabel, et al.
Publicado: (2023)

Mycobacterium tuberculosis complex bacteremia among HIV and non-HIV patients in a Mexican tertiary care center
por: Tamez-Torres, Karla Maria, et al.
Publicado: (2018)

782. Risk Factors, Clinical Characteristic, and Treatment Outcomes for Nontuberculous Mycobacterial Disease in Mexico
por: Luis, Bruno Ali Lopez, et al.
Publicado: (2018)

2375. Association Between Clostridium difficile Colonization and Inflammatory Bowel Disease Activity
por: Morado-Aramburo, Oscar, et al.
Publicado: (2019)

Nontuberculous mycobacterial infection in a tertiary care center in Mexico, 2001–2017
por: Lopez-Luis, Bruno Ali, et al.
Publicado: (2020)

Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus
por: Bobadilla-del-Valle, Miriam, et al.
Publicado: (2021)

Prevalence of Latent and Active Tuberculosis among Dairy Farm Workers Exposed to Cattle Infected by Mycobacterium bovis
por: Torres-Gonzalez, Pedro, et al.
Publicado: (2013)

rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism.
por: Bobadilla-del-Valle, M, et al.
Publicado: (2001)

Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance
por: Bobadilla-del Valle, Miriam, et al.
Publicado: (2015)

Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis
por: González-Lara, María Fernanda, et al.
Publicado: (2017)

573. Enterococcal Bacteremia in a Tertiary Care Center in Mexico: A Retrospective Analysis Focus on Vancomycin-Resistant E. faecium and Ampicillin-Resistant E. faecalis
por: Lopez Luis, Bruno A, et al.
Publicado: (2019)

Importance of differentiating Mycobaterium bovis in tuberculous meningitis
por: González-Duarte, Alejandra, et al.
Publicado: (2011)

Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital
por: Torres-Gonzalez, Pedro, et al.
Publicado: (2015)

Epidemiology of Invasive Fungal Infections in Latin America
por: Sifuentes-Osornio, Jose, et al.
Publicado: (2012)

Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis
por: Blanco-Guillot, Francles, et al.
Publicado: (2017)

Vancomycin-resistant Enterococci, Mexico City
por: Cuellar-Rodríguez, Jennifer, et al.
Publicado: (2007)

Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic
por: Martinez-Guerra, Bernardo A., et al.
Publicado: (2021)

Tuberculosis-Related Deaths within a Well-Functioning DOTS Control Program
por: García-García, Maria de Lourdes, et al.
Publicado: (2002)

Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial
por: Tamez-Torres, Karla M., et al.
Publicado: (2023)

Factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI) in a Mexican tertiary care hospital: A case-control study
por: Ochoa-Hein, Eric, et al.
Publicado: (2018)

Outbreak of NDM-1-Producing Escherichia coli in a Coronavirus Disease 2019 Intensive Care Unit in a Mexican Tertiary Care Center
por: Fernández-García, Oscar A., et al.
Publicado: (2022)

Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid
por: de Oyarzabal, Eleane, et al.
Publicado: (2019)

Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort study
por: Fernández-García, Oscar A., et al.
Publicado: (2022)

Effect of Fosfomycin on Cyclosporine Nephrotoxicity
por: Ortega-Trejo, Juan Antonio, et al.
Publicado: (2020)

Genotyping and spatial analysis of pulmonary tuberculosis and diabetes cases in the state of Veracruz, Mexico
por: Blanco-Guillot, Francles, et al.
Publicado: (2018)

Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes
por: Jiménez-Corona, María Eugenia, et al.
Publicado: (2013)

Results of the Implementation of a Pilot Model for the Bidirectional Screening and Joint Management of Patients with Pulmonary Tuberculosis and Diabetes Mellitus in Mexico
por: Castellanos-Joya, Martín, et al.
Publicado: (2014)

Surveillance of Antimicrobial Resistance in Hospital Wastewater: Identification of Carbapenemase-Producing Klebsiella spp.
por: Galarde-López, Miguel, et al.
Publicado: (2022)

Repurposing Simvastatin in Parkinson’s Disease Model: Protection Is throughout Modulation of the Neuro-Inflammatory Response in the Substantia nigra
por: Rubio-Osornio, Moisés, et al.
Publicado: (2023)

First case of Nocardia amamiensis pulmonary infection in Mexico
por: Martinez-Gamboa, A., et al.
Publicado: (2016)

Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010
por: Báez-Saldaña, Renata, et al.
Publicado: (2016)

High Glucose Concentrations Impair the Processing and Presentation of Mycobacterium tuberculosis Antigens In Vitro
por: Monroy-Mérida, Guadalupe, et al.
Publicado: (2021)

Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
por: Román-Montes, Carla Marina, et al.
Publicado: (2023)

Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
por: Rivera-Villegas, Hector Orlando, et al.
Publicado: (2023)

283. Post COVID-19 syndrome and quality of life impairment in a cohort of severe COVID-19
por: Roman-Montes, Carla M, et al.
Publicado: (2022)

Antimicrobial Resistance Patterns and Clonal Distribution of E. coli, Enterobacter spp. and Acinetobacter spp. Strains Isolated from Two Hospital Wastewater Plants
por: Galarde-López, Miguel, et al.
Publicado: (2022)

Aeroparticles, Composition, and Lung Diseases
por: Falcon-Rodriguez, Carlos I., et al.
Publicado: (2016)

Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients
por: Sada-Ovalle, Isabel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b6ct47i7lrbd0asnl8n9nao1he